期刊文献+

肺炎链球菌5型发酵工艺的优化 被引量:3

Optimization of Condition for The Fermentation Process of Streptococcus Pneumoniae Serotype 5
原文传递
导出
摘要 目的:采用正交试验设计方法进行肺炎链球菌5型发酵工艺的研究。方法:根据正交试验设计表L9(34)设计的试验条件组合进行了9次肺炎链球菌5型的发酵,采用70升发酵罐进行发酵工艺的摸索,提取了肺炎链球菌5型荚膜多糖粗糖。结果:最佳的发酵培养条件组合为温度37℃、葡萄糖20克/升、大豆胨15克/升、pH值7.3,最佳的纯化条件组合为冷酚抽提三次、沉核酸乙醇浓度23%、超滤膜孔径50kD、最终沉糖乙醇浓度60%,在此筛选得到的最佳条件下,连续进行了5个批次肺炎链球菌5型的发酵与荚膜多糖提取,荚膜多糖粗糖的平均收率为808.6mg/L,相对标准偏差为3.84%。结论:上述发酵培养条件组合适合用于肺炎多糖疫苗的研究和生产。 Objective:To investigate a good fermentation process of Streptococcus pneumoniae serotype 5 and capsular polysaccharide purification process of Streptococcus pneumoniae serotype 5.Methods: Streptococcus pneumoniae serotype 5 was cultured in 70 L fermenter with orthogonal experimental design,and purifying capsular polysaccharide.Results: The main quality indexes of the capsular polysaccharide of Streptococcus pneumoniae serotype 5 met the requirements of Europe Pharmacopeia 5.0.Conclusion: A successful process for large-scale production of Streptococcus pneumoniae serotype 5 capsular polysaccharide was established,and this procedure is suitable for pneumococcal vaccine production.
出处 《现代生物医学进展》 CAS 2012年第9期1660-1664,共5页 Progress in Modern Biomedicine
关键词 肺炎链球菌 发酵 正交试验设计 荚膜多糖 纯化 Streptococcus pneumoniae; Fermentation; Orthogonal experimental design; Capsular polysaccharide; Purification;
  • 相关文献

参考文献14

  • 1李凡,谷鸿喜,黄敏.医学微生物学[M].教育出版社,2004. 被引量:1
  • 2秦绍明,余绍珍.实用传染病手册[M].军医出版社,1994. 被引量:1
  • 3Butler JC,Breiman RF,Campbell JF,et al.Pneumococcal polysaccharide,vaccine efficacy[J].JAMA,1993,270:1826-1831. 被引量:1
  • 4杜荣骞编..生物统计学[M].北京:高等教育出版社,1985:502.
  • 5杨耀,栗克喜,宋绍忠,张云,江山,黄镇,谢全海,兰芳,黄健,毕俊红,邓雪莲,李凤祥,袁曾麟,郭淑英,石继春,何莉.23价肺炎链球菌荚膜多糖疫苗的研制[J].中国生物制品学杂志,2000,13(3):154-156. 被引量:15
  • 6王剑虹,乔瑞洁,王欣茹,沈荣,赵萍.肺炎链球菌培养及其荚膜多糖的制备[J].甘肃科学学报,2004,16(3):40-44. 被引量:4
  • 7Viviane Maimoni M.Gonclaves,Mickie Takagi,Rodrigo B.Lima et al.Purification of capsular polysaccharide from Streptococcus pneu-moniae serotype23F by a procedure suitable for scale-up Biotechnol.[J].Appl.Biochem,2003,37:283-287. 被引量:1
  • 8叶勤编著..发酵过程原理[M].北京:化学工业出版社,2005:248.
  • 9Auzat I,Chapuy R S,Bras G,el al.The NADH oxidase of Streptococ-cus Pneumoniae:Its involvement in competence and virulence[J].Mol.Microbiol,1999,34:1018-1028. 被引量:1
  • 10Baltz R H,Norris F H,Matsushima P,et al.DNA sequence sampling and gene disruption for idetification of new antibacterial targets in Streptococcus Pneumoniae[J].In Tomasz A(ed).Streptococcus pneumoniae:molecular biology and mechanisms of disease[M.Liebert,New York,2000:33-44. 被引量:1

二级参考文献24

  • 1[1]Recommendation of the public health service advisory committee on immunization practices pneumococcal polysaccharide vaccine. Morbidity and Mortality Weekly Report,1978,27(4):25. 被引量:1
  • 2[2]Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med,1964,60:759-776. 被引量:1
  • 3[3]Wenger J D, Hightower A W, Facklam R R, et al. Bacterial meningitis in the united states,1986:Report of a multistate surveillance study. J Infect Dis,1990,162:1316-1323. 被引量:1
  • 4[4]Fedson DS .Pneumococcal vaccine. In:Plotkin SA.Morhmer EA. Vaccines Philadelphia,Pa:WB Saunders Co,1988,271-299. 被引量:1
  • 5[5]Robbins JB, Austrian R, Lee CJ, et al. Considerations for formulating the second-generation Pneumococcal capsular polysaccharide vaccine with emphasis oa the cross-reactive types withen groups. J Infect Dis,1983,148:1136-1159. 被引量:1
  • 6Baltz R H, Norris F H, Matsushima P, et al. DNA Sequence Sampling and Gene Disruption for Identification of New Antibacterial Targets in Streptococcus Pneumoniae[M]. In:Tomasz A (ed). Streptococcus Pneumoniae: Molecular Biology and Mechanisms of Disease, 被引量:1
  • 7Dagan R, Muallem M, Melamed R, et al. Reduction of Pneumococcal Nasopharyngeal Carriage in Early Infancy After Immunization with Tetravalent Pneumococcal Vaccines Conjugated to either Tetanus Toxoid or Diphtheria Toxoid[J]. Pediatr Infect Dis J 1997,16:10 被引量:1
  • 8WHO Working Group. Streptococcus Pneumoniae Vaccine[J]. WHO/Weekly Epidemiological Record, 2003, 78(14):110-119. 被引量:1
  • 9Jackson L A, Neuzil K M, Yu O, et al. Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults[J]. N Engl J Med 2003, 348:1747-1755. 被引量:1
  • 10Whitney C G, Farley M M, Hadler J, et al. Decline in Invasive Pneumococcal Disease After the Introduction of Protein-polysaccharide Conjugate Vaccine[J]. N Engl J Med 2003, 348:1737-1746. 被引量:1

共引文献20

同被引文献19

  • 1吴凯,代泽友,马波,周燕美,吴绍学,樊会兰,黄镇.改进的蒽酮法检测肺炎链球菌荚膜多糖结合物中多糖浓度[J].中国生物制品学杂志,2007,20(7):536-538. 被引量:8
  • 2谢梅英,别智鑫.发酵技术[M].北京:化学工业出版社,2007:156. 被引量:5
  • 3史仲平,潘丰.发酵过程解析、控制与检测技术[M].第2版.北京:化学工业出版社,2010:30.34. 被引量:1
  • 4Morens DM,Taubenberger JK,Fauci AS.Predominant role of bacterial pneumonia as a cause of death in pandemic influenza:implications for pandemic influenza preparedness[J].J Infect Dis,2008,198(7):962-970. 被引量:1
  • 5Bednar B,Hennessey JP Jr.Molecular size analysis of capsular polysaccharide preparations from Streptococcus pneumonia[J].Carbohydr Res,1993,243(1):115-130. 被引量:1
  • 6World Health Organization.Recommendations to assure the quality,safety of pneumococcal conjugate vaccine[S].Geneva:WHO,2010. 被引量:1
  • 7European Directorate for the Quality of Medicines and Health Care.European Pharmacopoeia 7.0[S].Strasbourg:Council of Europe,2010. 被引量:1
  • 8Nagy DJ.Universal calibration in aqueous size exclusion chromatography with on-line differential viscometry using commercial TSK-PW columns[J].J Liq Chromatogr,1990,13(4):677-691. 被引量:1
  • 9Lesec J,Volet G.Data treatment in aqueous GPC with on-line viscometer and light scattering detectors[J].J Liq Chromatogr,1990,13(5):831-849. 被引量:1
  • 10于世林.高效液相色谱方法及应用[M].2版.北京:化学工业出版社,2010:157-159. 被引量:1

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部